Skip to main content
Top
Published in: World Journal of Surgery 4/2010

01-04-2010

Lymph Node Ratio Versus Number of Affected Lymph Nodes as Predictors of Survival for Resected Pancreatic Adenocarcinoma

Authors: Imran Bhatti, Oliver Peacock, Altaf K. Awan, David Semeraro, Michael Larvin, Richard I. Hall

Published in: World Journal of Surgery | Issue 4/2010

Login to get access

Abstract

Background

The objective of this study was to compare the prognostic significance of the lymph node ratio (LNR) with the absolute number of affected lymph nodes for resected pancreatic ductal adenocarcinoma.

Methods

Data were collected from 84 patients who had undergone pancreatoduodenectomy for pancreatic ductal adenocarcinoma over a 10-year period. Patients were categorized into four groups according to the absolute LNR (0, 0–0.199, 0.2–0.299, ≥0.3). Kaplan-Meier and Cox proportional hazard models were used to evaluate the prognostic effect.

Results

An LNR of ≥0.2 (median survival 8.1 vs. 35.7 months with LNR < 0.2; p < 0.001) and ≥0.3 (median survival 5.9 vs. 29.6 months with LNR < 0.3; p < 0.001), tumor size (p < 0.017), positive resection margin (p < 0.001), and nodal involvement (p < 0.001) were found to be significant prognostic markers following univariate analysis. Following multivariate analysis, only LNR at both levels [≥0.2 (p = 0.05; HR 1.8) and LNR of ≥0.3 (p = 0.01; HR 2.7)] were independent predictors of a poor outcome. The number of lymph nodes examined had no effect on overall survival in either node-positive patients (p = 0.339) or node-negative patients (p = 0.473).

Conclusions

The LNR represents a stronger independent prognostic indicator than the absolute number of affected lymph nodes in patients with resected pancreatic ductal adenocarcinoma.
Literature
1.
go back to reference James TA, Sheldon DG, Rajput A et al (2004) Risk factors associated with earlier age of onset in familial pancreatic carcinoma. Cancer 101:2722–2726CrossRefPubMed James TA, Sheldon DG, Rajput A et al (2004) Risk factors associated with earlier age of onset in familial pancreatic carcinoma. Cancer 101:2722–2726CrossRefPubMed
2.
go back to reference Alexakis N, Halloran C, Raraty M et al (2004) Current standards of surgery for pancreatic cancer. Br J Surg 91:1410–1427CrossRefPubMed Alexakis N, Halloran C, Raraty M et al (2004) Current standards of surgery for pancreatic cancer. Br J Surg 91:1410–1427CrossRefPubMed
3.
go back to reference Richter A, Niedergethmann M, Sturm JW et al (2003) Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 27:324–329CrossRefPubMed Richter A, Niedergethmann M, Sturm JW et al (2003) Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 27:324–329CrossRefPubMed
4.
go back to reference Connor S, Bosonnet L, Ghaneh P et al (2004) Survival of patients with periampullary carcinoma is predicted by lymph node 8a but not by lymph node 16b1 status. Br J Surg 91:1592–1599CrossRefPubMed Connor S, Bosonnet L, Ghaneh P et al (2004) Survival of patients with periampullary carcinoma is predicted by lymph node 8a but not by lymph node 16b1 status. Br J Surg 91:1592–1599CrossRefPubMed
5.
go back to reference Sierzega M, Popiela T, Kulig J et al (2006) The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer. Pancreas 33:240–245CrossRefPubMed Sierzega M, Popiela T, Kulig J et al (2006) The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer. Pancreas 33:240–245CrossRefPubMed
6.
go back to reference Berger AC, Watson JC, Ross EA et al (2004) The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg 70:235–240; discussion 240PubMed Berger AC, Watson JC, Ross EA et al (2004) The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg 70:235–240; discussion 240PubMed
7.
go back to reference Neoptolemos JP, Stocken DD, Dunn JA et al (2001) Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 234:758–768CrossRefPubMed Neoptolemos JP, Stocken DD, Dunn JA et al (2001) Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 234:758–768CrossRefPubMed
8.
go back to reference Winter JM, Cameron JL, Campbell KA et al (2006) 1423 Pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10:1199–1210; discussion 1210–1211CrossRefPubMed Winter JM, Cameron JL, Campbell KA et al (2006) 1423 Pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10:1199–1210; discussion 1210–1211CrossRefPubMed
9.
go back to reference Bassi C, Stocken DD, Olah A et al (2005) Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial. Dig Surg 22:353–363CrossRefPubMed Bassi C, Stocken DD, Olah A et al (2005) Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial. Dig Surg 22:353–363CrossRefPubMed
10.
go back to reference Ueda M, Endo I, Nakashima M et al (2009) Prognostic factors after resection of pancreatic cancer. World J Surg 33:104–110CrossRefPubMed Ueda M, Endo I, Nakashima M et al (2009) Prognostic factors after resection of pancreatic cancer. World J Surg 33:104–110CrossRefPubMed
11.
go back to reference Kure S, Kaneko T, Takeda S et al (2005) Analysis of long-term survivors after surgical resection for invasive pancreatic cancer. HPB (Oxford) 7:129–134 Kure S, Kaneko T, Takeda S et al (2005) Analysis of long-term survivors after surgical resection for invasive pancreatic cancer. HPB (Oxford) 7:129–134
12.
go back to reference Sohn TA, Yeo CJ, Cameron JL et al (2000) Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4:567–579CrossRefPubMed Sohn TA, Yeo CJ, Cameron JL et al (2000) Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4:567–579CrossRefPubMed
13.
go back to reference House MG, Gonen M, Jarnagin WR et al (2007) Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg 11:1549–1555CrossRefPubMed House MG, Gonen M, Jarnagin WR et al (2007) Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg 11:1549–1555CrossRefPubMed
14.
go back to reference Pawlik TM, Gleisner AL, Cameron JL et al (2007) Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 141:610–618CrossRefPubMed Pawlik TM, Gleisner AL, Cameron JL et al (2007) Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 141:610–618CrossRefPubMed
15.
go back to reference Tamandl D, Kaczirek K, Gruenberger B et al (2009) Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma. Br J Surg 96:919–925CrossRefPubMed Tamandl D, Kaczirek K, Gruenberger B et al (2009) Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma. Br J Surg 96:919–925CrossRefPubMed
16.
go back to reference Kulig J, Sierzega M, Kolodziejczyk P et al (2009) Ratio of metastatic to resected lymph nodes for prediction of survival in patients with inadequately staged gastric cancer. Br J Surg 96:910–918CrossRefPubMed Kulig J, Sierzega M, Kolodziejczyk P et al (2009) Ratio of metastatic to resected lymph nodes for prediction of survival in patients with inadequately staged gastric cancer. Br J Surg 96:910–918CrossRefPubMed
17.
go back to reference Riediger H, Keck T, Wellner U et al (2009) The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg 13:1337–1344CrossRefPubMed Riediger H, Keck T, Wellner U et al (2009) The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg 13:1337–1344CrossRefPubMed
18.
go back to reference Brennan MF, Kattan MW, Klimstra D et al (2004) Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 240:293–298CrossRefPubMed Brennan MF, Kattan MW, Klimstra D et al (2004) Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 240:293–298CrossRefPubMed
19.
go back to reference Lim JE, Chien MW, Earle CC (2003) Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 237:74–85CrossRefPubMed Lim JE, Chien MW, Earle CC (2003) Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 237:74–85CrossRefPubMed
20.
go back to reference Breslin TM, Hess KR, Harbison DB et al (2001) Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol 8:123–132CrossRefPubMed Breslin TM, Hess KR, Harbison DB et al (2001) Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol 8:123–132CrossRefPubMed
21.
go back to reference Bogoevski D, Onken F, Koenig A et al (2008) Is it time for a new TNM classification in esophageal carcinoma? Ann Surg 247:633–641CrossRefPubMed Bogoevski D, Onken F, Koenig A et al (2008) Is it time for a new TNM classification in esophageal carcinoma? Ann Surg 247:633–641CrossRefPubMed
22.
go back to reference Sierra A, Regueira FM, Hernandez-Lizoain JL et al (2003) Role of the extended lymphadenectomy in gastric cancer surgery: experience in a single institution. Ann Surg Oncol 10:219–226CrossRefPubMed Sierra A, Regueira FM, Hernandez-Lizoain JL et al (2003) Role of the extended lymphadenectomy in gastric cancer surgery: experience in a single institution. Ann Surg Oncol 10:219–226CrossRefPubMed
23.
go back to reference Rosenberg R, Friederichs J, Schuster T et al (2008) Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3, 026 patients over a 25-year time period. Ann Surg 248:968–978CrossRefPubMed Rosenberg R, Friederichs J, Schuster T et al (2008) Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3, 026 patients over a 25-year time period. Ann Surg 248:968–978CrossRefPubMed
Metadata
Title
Lymph Node Ratio Versus Number of Affected Lymph Nodes as Predictors of Survival for Resected Pancreatic Adenocarcinoma
Authors
Imran Bhatti
Oliver Peacock
Altaf K. Awan
David Semeraro
Michael Larvin
Richard I. Hall
Publication date
01-04-2010
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 4/2010
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-009-0336-4

Other articles of this Issue 4/2010

World Journal of Surgery 4/2010 Go to the issue